{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:52:59Z","timestamp":1761663179623},"reference-count":85,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Liver Disease"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.cld.2013.05.008","type":"journal-article","created":{"date-parts":[[2013,7,8]],"date-time":"2013-07-08T14:01:44Z","timestamp":1373292104000},"page":"489-501","source":"Crossref","is-referenced-by-count":19,"title":["Hepatitis B in HIV-Infected Patients"],"prefix":"10.1016","volume":"17","author":[{"given":"Vincent","family":"Soriano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Poveda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Vispo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cld.2013.05.008_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2009.11.009","article-title":"Epidemiology of hepatitis B and C viruses: a global overview","volume":"14","author":"Te","year":"2010","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib2","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1097\/01.aids.0000163936.99401.fe","article-title":"Hepatitis B and HIV: prevalence, AIDS progression, response to HAART and increased mortality in the EuroSIDA cohort","volume":"19","author":"Konopnicki","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib3","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/377135","article-title":"Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in HIV-infected participants","volume":"188","author":"Kellerman","year":"2003","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib4","first-page":"25","article-title":"Viral hepatitis and HIV in Africa","volume":"9","author":"Modi","year":"2007","journal-title":"AIDS Rev"},{"key":"10.1016\/j.cld.2013.05.008_bib5","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/649885","article-title":"Epidemiology of hepatitis B virus infection in a US cohort of HIV-infected individuals during the past 20 years","volume":"50","author":"Chun","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1365-2893.2003.00487.x","article-title":"Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures","volume":"11","author":"Lavanchy","year":"2004","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2013.05.008_bib7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/jac\/dkp479","article-title":"Predictors of hepatitis B virus genotype and viraemia in HIV-infected patients with chronic hepatitis B in Europe","volume":"65","author":"Soriano","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cld.2013.05.008_bib8","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/QCO.0b013e328357f2f8","article-title":"Diagnosis and personalized management of hepatitis B including significance of genotypes","volume":"25","author":"Wong","year":"2012","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/hep.21051","article-title":"Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy","volume":"43","author":"Yeo","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2013.05.008_bib10","doi-asserted-by":"crossref","first-page":"759","DOI":"10.7326\/0003-4819-135-9-200111060-00006","article-title":"Serologic and clinical outcomes of 1536 Alaska natives chronically infected with hepatitis B virus","volume":"135","author":"McMahon","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cld.2013.05.008_bib11","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.510310330","article-title":"Hepatitis B e antigen-negative chronic hepatitis B in Hong Kong","volume":"31","author":"Chan","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2013.05.008_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0168-8278(00)80279-2","article-title":"Rapid detection of genotypes and mutations in the pre-core promoter and the pre-core region of hepatitis B virus genome: correlation with viral persistence and disease severity","volume":"33","author":"Grandjacques","year":"2000","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl","key":"10.1016\/j.cld.2013.05.008_bib13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/hep.22898","article-title":"The natural history of chronic hepatitis B virus infection","volume":"49","author":"McMahon","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2013.05.008_bib14","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B virus viral load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2013.05.008_bib15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2013.05.008_bib16","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/j.jhep.2005.11.015","article-title":"Natural history of chronic hepatitis B in co-infected patients","volume":"44","author":"Puoti","year":"2006","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2013.05.008_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jhep.2010.08.035","article-title":"Trends in mortality after diagnosis of hepatitis B or C infection: 1992\u20132006","volume":"54","author":"Walter","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2013.05.008_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/QAD.0b013e328340fde2","article-title":"Clinical and virological outcomes in HIV-infected patients with chronic hepatitis B on long-term nucleos(t)ide analogues","volume":"25","author":"Mart\u00edn-Carbonero","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib19","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1097\/QAD.0b013e32831103ad","article-title":"Influence of HIV-related immunodeficiency on the risk of hepatocellular carcinoma","volume":"22","author":"Clifford","year":"2008","journal-title":"AIDS"},{"issue":"Suppl","key":"10.1016\/j.cld.2013.05.008_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/hep.22883","article-title":"Hepatitis B and human immunodeficiency virus coinfection","volume":"49","author":"Thio","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2013.05.008_bib21","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","article-title":"Liver-related deaths in persons with the human immunodeficiency virus: the D:A:D study","volume":"166","author":"Weber","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cld.2013.05.008_bib22","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1086\/599110","article-title":"Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: a cohort study and meta-analysis","volume":"48","author":"Nikolopoulos","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib23","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.cld.2013.05.008_bib24","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1097\/QAD.0b013e32832e463a","article-title":"Hepatitis B and long-term HIV outcomes in coinfected HAART recipients","volume":"23","author":"Hoffmann","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib25","unstructured":"DHHS. Panel on treatment of HIV-infected pregnant women and prevention of perinatal transmission. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV transmission in the United States. Available at: http:\/\/aidsinfo.nih.gov\/contentfiles\/lvguidelines\/perinatalgl.pdf."},{"key":"10.1016\/j.cld.2013.05.008_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/jama.2012.7961","article-title":"Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel","volume":"308","author":"Thompson","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2013.05.008_bib27","unstructured":"European AIDS Clinical Society Guidelines. Version 6.0. October 2011. Available at: http:\/\/www.europeanaidsclinicalsociety.org."},{"issue":"1","key":"10.1016\/j.cld.2013.05.008_bib28","first-page":"13","article-title":"Hepatitis B in HIV patients: what is the current treatment and what are the challenges?","volume":"14","author":"Soriano","year":"2009","journal-title":"J\u00a0HIV Ther"},{"key":"10.1016\/j.cld.2013.05.008_bib29","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1001\/jama.283.1.74","article-title":"Hepatotoxicity associated with antiretroviral therapy in adults infected with HIV and the role of hepatitis C or B virus infection","volume":"283","author":"Sulkowski","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2013.05.008_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/00042560-200201010-00005","article-title":"Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV: the role of hepatitis B and C virus infection","volume":"29","author":"Aceti","year":"2002","journal-title":"J\u00a0Acquir Immune Defic Syndr"},{"key":"10.1016\/j.cld.2013.05.008_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/QAD.0b013e3282f0e2fd","article-title":"Antiretroviral drugs and liver injury","volume":"22","author":"Soriano","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib32","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1097\/QAD.0b013e3282f8b46f","article-title":"Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B virus international panel","volume":"22","author":"Soriano","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib33","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2013.05.008_bib34","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2008.10.001","article-title":"EASL Clinical Practice Guidelines: management of chronic hepatitis B","volume":"50","author":"European Association for the Study of the Liver","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2013.05.008_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.aids.0000200538.25103.3a","article-title":"Confronting chronic hepatitis B virus infection in HIV: new diagnostic tools and more weapons","volume":"20","author":"Soriano","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib36","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1056\/NEJMoa067710","article-title":"The HBV drug entecavir - effects on HIV-1 replication and resistance","volume":"356","author":"McMahon","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2013.05.008_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkn175","article-title":"Why are there different dynamics in the selection of drug resistance in HIV and hepatitis B and C viruses?","volume":"62","author":"Soriano","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cld.2013.05.008_bib38","first-page":"275","article-title":"Hepatitis B therapy","volume":"8","author":"Known","year":"2011","journal-title":"Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2013.05.008_bib39","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/135965350701200509","article-title":"A\u00a0novel mutation pattern emerging during lamivudine treatment shows cross-resistance to adefovir dipivoxil treatment","volume":"12","author":"Karatayli","year":"2007","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cld.2013.05.008_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3851\/IMP1504","article-title":"Genotypic determinants and phenotypic properties of antiviral-resistant HBV variants: insight from entecavir resistance studies","volume":"15","author":"Tenney","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cld.2013.05.008_bib41","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/135965350501000612","article-title":"Selection of hepatitis B virus polymerase mutations in HIV coinfected patients treated with tenofovir","volume":"10","author":"Sheldon","year":"2005","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cld.2013.05.008_bib42","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/hep.510300525","article-title":"Long-term incidence of hepatitis B virus resistance to lamivudine in HIV-infected patients","volume":"30","author":"Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2013.05.008_bib43","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1086\/593104","article-title":"Hepatitis B virus infection and response to antiretroviral therapy (ART) in a South African ART program","volume":"47","author":"Hoffmann","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib44","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1086\/593105","article-title":"Risks and benefits of using antiretroviral therapy in HIV-infected patients with chronic hepatitis B in developing regions","volume":"47","author":"Soriano","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib45","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/01.aids.0000218550.85081.59","article-title":"Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy","volume":"20","author":"Matthews","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib46","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1097\/01.aids.0000131384.53350.59","article-title":"Severe hepatitis and prolonged hepatitis B virus-specific CD8 T-cell response after selection of hepatitis B virus YMDD variant in an HIV\/hepatitis B virus co-infected patient","volume":"18","author":"Gouskos","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib47","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/j.gastro.2006.12.001","article-title":"Identification of a hepatitis B virus S gene mutant in lamivudine-treated patients experiencing HBsAg seroclearance","volume":"132","author":"Hsu","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2013.05.008_bib48","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/jac\/dkn014","article-title":"Hepatitis B virus escape mutants induced by antiviral therapy","volume":"61","author":"Sheldon","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cld.2013.05.008_bib49","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/jac\/dkp492","article-title":"New paradigms for treating hepatitis B in HIV\/HBV co-infected patients","volume":"65","author":"Mart\u00edn-Carbonero","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cld.2013.05.008_bib50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/00002030-200201040-00020","article-title":"Primary infection with a lamivudine-resistant hepatitis B virus","volume":"16","author":"Thibault","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib51","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3851\/IMP1778","article-title":"HBV primary drug resistance in newly diagnosed HIV-HBV-coinfected individuals in Spain","volume":"16","author":"Tuma","year":"2011","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cld.2013.05.008_bib52","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1128\/JCM.02149-10","article-title":"Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan","volume":"49","author":"Fujisaki","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cld.2013.05.008_bib53","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jcv.2010.05.010","article-title":"Acute hepatitis B infection associated with drug resistant hepatitis B virus","volume":"48","author":"Xu","year":"2010","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cld.2013.05.008_bib54","unstructured":"Fung S, Mazulli T, El-Kashab M, et\u00a0al. Lamivudine-resistant mutation among treatment-na\u00efve hepatitis B patients is common and may be associated with treatment failure. American Association for the Study of Liver Diseases. 31 Oct-4 Nov 2008; San Francisco, CA, USA [Abstract 888]."},{"key":"10.1016\/j.cld.2013.05.008_bib55","unstructured":"Soriano V, McMahon B. Rethinking therapeutic strategies for hepatitis B. J Antimicrob Chemother, in press."},{"key":"10.1016\/j.cld.2013.05.008_bib56","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1053\/j.gastro.2003.09.033","article-title":"Long-term safety of lamivudine treatment in patients with chronic hepatitis B","volume":"125","author":"Lok","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2013.05.008_bib57","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/QAD.0b013e3283262a64","article-title":"Kidney tubular abnormalities in the absence of impaired glomerular function in HIV patients treated with tenofovir","volume":"23","author":"Labarga","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib58","first-page":"179","article-title":"Proximal tubular renal dysfunction or damage in HIV-infected patients","volume":"14","author":"Del Palacio","year":"2012","journal-title":"AIDS Rev"},{"key":"10.1016\/j.cld.2013.05.008_bib59","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.amjmed.2004.03.025","article-title":"Tenofovir-associated nephrotoxicity: Fanconi syndrome and renal failure","volume":"117","author":"Rifkin","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.cld.2013.05.008_bib60","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1086\/368314","article-title":"Tenofovir-related nephrotoxicity in HIV-infected patients: three cases of renal failure, Fanconi syndrome, and nephrogenic diabetes insipidus","volume":"36","author":"Karras","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib61","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e32835192ae","article-title":"Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents","volume":"26","author":"Bedimo","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib62","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jhep.2008.12.018","article-title":"Early changes of HBV quasispecies during lamivudine treatment and the correlation with antiviral efficacy","volume":"50","author":"Chen","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2013.05.008_bib63","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2005.02.021","article-title":"Virus and transaminase levels determine the emergence of drug resistance during long-term lamivudine therapy in chronic hepatitis B","volume":"43","author":"Chang","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cld.2013.05.008_bib64","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cgh.2012.10.003","article-title":"Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis","volume":"11","author":"Koklu","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cld.2013.05.008_bib65","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2012.09.014","article-title":"Evaluation of anti-HBV drug resistant mutations among patients with acute symptomatic hepatitis B in the United States","volume":"58","author":"Baxa","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.cld.2013.05.008_bib66","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/0264-410X(95)93547-M","article-title":"Global programme for control of hepatitis B infection","volume":"13","author":"Kane","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.cld.2013.05.008_bib67","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jcv.2011.07.014","article-title":"HIV\u2013HBV vaccine escape mutant infection with loss of HBV surface antibody and persistent HBV viremia on tenofovir\/emtricitabine without antiviral resistance","volume":"52","author":"Schirmera","year":"2011","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cld.2013.05.008_bib68","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/429302","article-title":"Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies","volume":"191","author":"Gandhi","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib69","first-page":"173","article-title":"Immunizations in HIV-infected adults","volume":"9","author":"Rivas","year":"2007","journal-title":"AIDS Rev"},{"key":"10.1016\/j.cld.2013.05.008_bib70","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1001\/jama.2011.351","article-title":"Safety and immunogenicity of 4 intramuscular double doses and 4 intradermal low doses vs standard hepatitis B vaccine regimen in adults with HIV-1: a randomized controlled trial","volume":"305","author":"Launay","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.cld.2013.05.008_bib71","first-page":"405","article-title":"Hepatitis B vaccines: WHO position paper","volume":"84","author":"World Health Organisation","year":"2009","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.cld.2013.05.008_bib72","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.21590","article-title":"Hepatitis D virus infection\u2014not a vanishing disease in Europe!","volume":"45","author":"Wedemeyer","year":"2007","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2013.05.008_bib73","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1097\/QAD.0b013e32834babb3","article-title":"Hepatitis delta in HIV-infected individuals in Europe","volume":"25","author":"Soriano","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.cld.2013.05.008_bib74","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1055\/s-0032-1316467","article-title":"Hepatitis delta and HIV infection","volume":"32","author":"Calle-Serrano","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib75","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/jvh.12043","article-title":"Hepatitis viruses (other than hepatitis B and C viruses) as causes of hepatocellular carcinoma: an update","volume":"20","author":"Kew","year":"2013","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2013.05.008_bib76","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1055\/s-0032-1323628","article-title":"Clinical features of hepatitis D","volume":"32","author":"Farci","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib77","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1478-3231.2006.01279.x","article-title":"Treatment of chronic hepatitis D with pegylated interferon-a 2b","volume":"26","author":"Erhardt","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.cld.2013.05.008_bib78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1055\/s-0032-1323629","article-title":"Treatment of chronic delta hepatitis","volume":"32","author":"Yurdaydin","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.cld.2013.05.008_bib79","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1053\/j.gastro.2004.03.017","article-title":"Long-term benefit of interferon a therapy of chronic hepatitis D: regression of advanced hepatic fibrosis","volume":"126","author":"Farci","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cld.2013.05.008_bib80","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.21296","article-title":"Pegylated interferon alpha 2b as monotherapy or in combination with ribavirin in chronic hepatitis D","volume":"44","author":"Niro","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2013.05.008_bib81","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/j.1365-2893.2007.00936.x","article-title":"Treatment of chronic d hepatitis with lamivudine vs lamivudine+ interferon vs interferon","volume":"15","author":"Yurdaydin","year":"2008","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cld.2013.05.008_bib82","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa0912696","article-title":"Peginterferon plus adefovir versus either drug alone for hepatitis delta","volume":"364","author":"Wedemeyer","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cld.2013.05.008_bib83","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/135965350801300110","article-title":"Does treatment of hepatitis B virus (HBV) infection reduce hepatitis delta virus (HDV) replication in HIV-HBV-HDV-coinfected patients?","volume":"13","author":"Sheldon","year":"2008","journal-title":"Antivir Ther"},{"key":"10.1016\/j.cld.2013.05.008_bib84","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/hep.21351","article-title":"Treatment of chronic hepatitis D: new advances, old challenges","volume":"44","author":"Farci","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cld.2013.05.008_bib85","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1055\/s-0032-1323630","article-title":"Liver transplantation in delta virus infection","volume":"32","author":"Roche","year":"2012","journal-title":"Semin Liver Dis"}],"container-title":["Clinics in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326113000287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1089326113000287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T23:32:48Z","timestamp":1688340768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1089326113000287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":85,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1089326113000287"],"URL":"https:\/\/doi.org\/10.1016\/j.cld.2013.05.008","relation":{},"ISSN":["1089-3261"],"issn-type":[{"value":"1089-3261","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}